Tempus Expands Next Platform to Deliver Real-Time Clinical Intelligence and Close Critical Care Gaps Across Oncology

Go back to Tempus Expands Next Platform to Deliver Real-Time Clinical Intelligence and Close Critical Care Gaps Across Oncology
StemCells, Inc. (NASDAQ: TEM) Delayed: 48.61 +0.76 (1.59%)
Previous Close $47.85    52 Week High $0.45 
Open $47.00    52 Week Low $0.37 
Day High $49.85    P/E N/A 
Day Low $46.68    EPS $-0.31 
Volume 4,966,783